Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: A preliminary study

Diabetes Technology and Therapeutics

Volumn 8, Issue 1, 2006, Pages 81-88

  Leary, Andrew C ^a,b   Stote, Robert M ^c   Cussen, Kathleen ^b   O'Brien, Jackie ^b   Leary, William P ^a,b   Buckley, Brendan ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Shandon Clinic Cork Ireland   (Ireland)

^c Bentley Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; METABOLIC CLEARANCE RATE; PLACEBOS;

EID: 33645295252     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.81     Document Type: Article

References (12)

1. Leary AC, Stote RM, Breedt HJ, O'Brien J, Buckley B: Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses. Diabetes Technol Ther 2005;7:124-130.
2. Drejer K, Vaag A, Bech K, Hansen P, Sorensen AR, Mygind N: Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabet Med 1992;9:335-340.
3. Haruta S, Hanafusa T, Fukase H, Miyajima H, Oki T: An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers. Diabetes Technol Ther 2003;5:1-9.
4. Paquot N, Scheen AJ, Franchimont P, Lefebvre PJ: The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabetes Metab 1988;14:31-36.
5. Newman SP, Steed KP, Hardy JG, Wilding IR, Hooper G, Sparrow RA: The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J Pharm Pharmacol 1994;46:657-660.
6. Nolte MS, Taboga C, Salamon E, Moses A, Longenecker J, Flier J, Karam JH: Biological activity of nasally administered insulin in normal subjects. Horm Metab Res 1990;22:170-174.
7. Jacobs MA, Schreuder RH, Jap AJ, Nauta JJ, Andersen PM, Heine RJ: The pharmacodynamics and activity of intranasally administered insulin in healthy male volunteers. Diabetes 1993;42:1649-1655.
8. Pontiroli AE, Alberetto M, Secchi A, Dossi G, Bosi I, Pozza G: Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. BMJ (Clin Res Ed) 1982;284:303-306.
9. Moses AC, Gordon GS, Carey MC, Flier JS: Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects. Diabetes 1983;32:1040-1047.
10. Salzman R, Manson JE, Griffing GT, Kimmerle R, Ruderman N, McCall A, Stoltz EI, Mullin C, Small D, Armstrong J: Intranasal aerosolized insulin. Mixed-meal studies and long-term use in Type 1 diabetes. N Engl J Med 1985;312:1078-1084.
11. Sinay IR, Schlimovich S, Damilano S, Cagide AL, Faingold MC, Facco EB, Gurfinkiel MS, Arias P: Intranasal insulin administration in insulin dependent diabetes: reproducibility of its absorption and effects. Horm Metab Res 1990;22:307-308.
12. Hinchcliffe M, Ilium L: Intranasal insulin delivery and therapy. Adv Drug Deliv Rev 1999;35:199-234.